Objectif
The research network, EUROME, represents Centers of Excellence in Europe where recent technologies in transcriptome (microarrays) as well as proteome analysis are applied to study with the use of transgenic and congenic animal models human autoimmune diseases primarily rheumatoid arthritis (RA). Susceptibility genes for autoimmune diseases are identified and their functions are determined. Targets for studying novel treatments are evaluated i.e. to stop neoangiogenesis in inflamed tissues. Gene and cell based intervention strategies are investigated to treat autoimmune diseases (rheumatoid arthritis). Common mechanisms that cause autoimmune diseases are determined. EUROM research leads to a genome-base individualized medicine.
Champ scientifique
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomics
- medical and health sciencesclinical medicinerheumatology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationstelecommunications networksmobile network
- medical and health sciencesbasic medicineimmunologyautoimmune diseases
Appel à propositions
Data not availableRégime de financement
CSC - Cost-sharing contractsCoordinateur
18055 ROSTOCK
Allemagne